Global Avian Influenza Vaccines research

Avian Influenza Vaccines Comprehensive Study by Type (Inactivated Vaccines, Live Recombinant Vaccines, Combination Vaccines), Application (Chicken, Duck & Goose, Others), Strain (H5 Strain, H7 Strain, H9 Strain) Players and Region - Global Market Outlook to 2030

Avian Influenza Vaccines Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Avian Influenza Vaccines Market Scope
Avian influenza refers to the infectious disease caused by the bird flu Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Humans can also get affected by the infection if the virus enters the eyes, nose, or mouth. The avian influenza vaccine market is expected to grow in the future due to the increasing prevalence of infection and the growing demand for poultry consumption. It widely finds its application in Duck, Chicken, Goose, and other birds.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledBoehringer Ingelheim Animal Health (France), QianYuanHao Biological Corporation Limited (China), Harbin Veterinary Research Institute (China), CEVA (France), Qingdao Yebio Biological Engineering Co., Ltd (China), Zoetis Inc. (United States), FATRO S.p.A. (Italy) and Merck Animal Health (United States)
CAGR%


Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Avian Influenza Vaccines market throughout the predicted period.

Boehringer Ingelheim Animal Health (France), QianYuanHao Biological Corporation Limited (China), Harbin Veterinary Research Institute (China), CEVA (France), Qingdao Yebio Biological Engineering Co., Ltd (China), Zoetis Inc. (United States), FATRO S.p.A. (Italy) and Merck Animal Health (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Avian Influenza Vaccines market by Type , by Application (Chicken, Duck & Goose and Others) and Region with country level break-up.

On the basis of geography, the market of Avian Influenza Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In July 2019, Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH (“IDT”) announced that they have successfully completed the acquisition of IDT’s veterinary biopharmaceutical and R&D activities by Ceva.
In Sept 2019, Boehringer Ingelheim is developing one of the largest biotechnology production sites for veterinary vaccines in Europe, building on France’s pioneering expertise in veterinary public health (VPN)., and On 26 April 2018, Zoetis announced to expand animal vaccine research and manufacturing in Suzhou, China. The company begins the construction of state-of-the-art vaccine manufacturing and research and development facilities in Suzhou to support growth. Operations to focus on the development and manufacturing of vaccines for pigs, cattle and fish and companion animals tailored to the animal health needs of China.


Influencing Trend:
Collaboration and Tie Up Of Leading Players

Market Growth Drivers:
Increasing Awareness About the Avian Influenza Vaccines and Growing Demand from Poultry Consumption

Challenges:
Lack of Awareness about the Disease among People who Maintain Poultry

Restraints:
Issues Regarding Vaccine Degradation at Room Temperature

Opportunities:
Increasing R&D Expenses for New Vaccines and Rising Government Initiatives for Vaccines against Avian Influenza

Key Target Audience
Influenza Vaccines Manufacturers, Influenza Vaccines Traders, End-Use Market Participants of Different Segments of Influenza Vaccines, Government and Research Organizations, R&D Institutions and Others

Report Objectives / Segmentation Covered

By Type
  • Inactivated Vaccines
  • Live Recombinant Vaccines
  • Combination Vaccines
By Application
  • Chicken
  • Duck & Goose
  • Others
By Strain
  • H5 Strain
  • H7 Strain
  • H9 Strain

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness About the Avian Influenza Vaccines
      • 3.2.2. Growing Demand from Poultry Consumption
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness about the Disease among People who Maintain Poultry
    • 3.4. Market Trends
      • 3.4.1. Collaboration and Tie Up Of Leading Players
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Avian Influenza Vaccines, by Type, Application, Strain and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Avian Influenza Vaccines (Value)
      • 5.2.1. Global Avian Influenza Vaccines by: Type (Value)
        • 5.2.1.1. Inactivated Vaccines
        • 5.2.1.2. Live Recombinant Vaccines
        • 5.2.1.3. Combination Vaccines
      • 5.2.2. Global Avian Influenza Vaccines by: Application (Value)
        • 5.2.2.1. Chicken
        • 5.2.2.2. Duck & Goose
        • 5.2.2.3. Others
      • 5.2.3. Global Avian Influenza Vaccines by: Strain (Value)
        • 5.2.3.1. H5 Strain
        • 5.2.3.2. H7 Strain
        • 5.2.3.3. H9 Strain
      • 5.2.4. Global Avian Influenza Vaccines Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Avian Influenza Vaccines (Price)
      • 5.3.1. Global Avian Influenza Vaccines by: Type (Price)
  • 6. Avian Influenza Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer Ingelheim Animal Health (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. QianYuanHao Biological Corporation Limited (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Harbin Veterinary Research Institute (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CEVA (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Qingdao Yebio Biological Engineering Co., Ltd (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Zoetis Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. FATRO S.p.A. (Italy)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merck Animal Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Avian Influenza Vaccines Sale, by Type, Application, Strain and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Avian Influenza Vaccines (Value)
      • 7.2.1. Global Avian Influenza Vaccines by: Type (Value)
        • 7.2.1.1. Inactivated Vaccines
        • 7.2.1.2. Live Recombinant Vaccines
        • 7.2.1.3. Combination Vaccines
      • 7.2.2. Global Avian Influenza Vaccines by: Application (Value)
        • 7.2.2.1. Chicken
        • 7.2.2.2. Duck & Goose
        • 7.2.2.3. Others
      • 7.2.3. Global Avian Influenza Vaccines by: Strain (Value)
        • 7.2.3.1. H5 Strain
        • 7.2.3.2. H7 Strain
        • 7.2.3.3. H9 Strain
      • 7.2.4. Global Avian Influenza Vaccines Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Avian Influenza Vaccines (Price)
      • 7.3.1. Global Avian Influenza Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Avian Influenza Vaccines: by Type(USD Million)
  • Table 2. Avian Influenza Vaccines Inactivated Vaccines , by Region USD Million (2018-2023)
  • Table 3. Avian Influenza Vaccines Live Recombinant Vaccines , by Region USD Million (2018-2023)
  • Table 4. Avian Influenza Vaccines Combination Vaccines , by Region USD Million (2018-2023)
  • Table 5. Avian Influenza Vaccines: by Application(USD Million)
  • Table 6. Avian Influenza Vaccines Chicken , by Region USD Million (2018-2023)
  • Table 7. Avian Influenza Vaccines Duck & Goose , by Region USD Million (2018-2023)
  • Table 8. Avian Influenza Vaccines Others , by Region USD Million (2018-2023)
  • Table 9. Avian Influenza Vaccines: by Strain(USD Million)
  • Table 10. Avian Influenza Vaccines H5 Strain , by Region USD Million (2018-2023)
  • Table 11. Avian Influenza Vaccines H7 Strain , by Region USD Million (2018-2023)
  • Table 12. Avian Influenza Vaccines H9 Strain , by Region USD Million (2018-2023)
  • Table 13. South America Avian Influenza Vaccines, by Country USD Million (2018-2023)
  • Table 14. South America Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 15. South America Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 16. South America Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 17. Brazil Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 18. Brazil Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 19. Brazil Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 20. Argentina Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 21. Argentina Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 22. Argentina Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 23. Rest of South America Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 25. Rest of South America Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 26. Asia Pacific Avian Influenza Vaccines, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 29. Asia Pacific Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 30. China Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 31. China Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 32. China Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 33. Japan Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 34. Japan Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 35. Japan Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 36. India Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 37. India Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 38. India Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 39. South Korea Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 40. South Korea Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 41. South Korea Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 42. Taiwan Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 43. Taiwan Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 44. Taiwan Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 45. Australia Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 46. Australia Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 47. Australia Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 51. Europe Avian Influenza Vaccines, by Country USD Million (2018-2023)
  • Table 52. Europe Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 53. Europe Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 54. Europe Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 55. Germany Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 56. Germany Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 57. Germany Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 58. France Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 59. France Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 60. France Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 61. Italy Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 62. Italy Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 63. Italy Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 64. United Kingdom Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 65. United Kingdom Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 66. United Kingdom Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 67. Netherlands Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 68. Netherlands Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 69. Netherlands Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 70. Rest of Europe Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 71. Rest of Europe Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 72. Rest of Europe Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 73. MEA Avian Influenza Vaccines, by Country USD Million (2018-2023)
  • Table 74. MEA Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 75. MEA Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 76. MEA Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 77. Middle East Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 78. Middle East Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 79. Middle East Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 80. Africa Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 81. Africa Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 82. Africa Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 83. North America Avian Influenza Vaccines, by Country USD Million (2018-2023)
  • Table 84. North America Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 85. North America Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 86. North America Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 87. United States Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 88. United States Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 89. United States Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 90. Canada Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 91. Canada Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 92. Canada Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 93. Mexico Avian Influenza Vaccines, by Type USD Million (2018-2023)
  • Table 94. Mexico Avian Influenza Vaccines, by Application USD Million (2018-2023)
  • Table 95. Mexico Avian Influenza Vaccines, by Strain USD Million (2018-2023)
  • Table 96. Avian Influenza Vaccines: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Avian Influenza Vaccines: by Type(USD Million)
  • Table 106. Avian Influenza Vaccines Inactivated Vaccines , by Region USD Million (2025-2030)
  • Table 107. Avian Influenza Vaccines Live Recombinant Vaccines , by Region USD Million (2025-2030)
  • Table 108. Avian Influenza Vaccines Combination Vaccines , by Region USD Million (2025-2030)
  • Table 109. Avian Influenza Vaccines: by Application(USD Million)
  • Table 110. Avian Influenza Vaccines Chicken , by Region USD Million (2025-2030)
  • Table 111. Avian Influenza Vaccines Duck & Goose , by Region USD Million (2025-2030)
  • Table 112. Avian Influenza Vaccines Others , by Region USD Million (2025-2030)
  • Table 113. Avian Influenza Vaccines: by Strain(USD Million)
  • Table 114. Avian Influenza Vaccines H5 Strain , by Region USD Million (2025-2030)
  • Table 115. Avian Influenza Vaccines H7 Strain , by Region USD Million (2025-2030)
  • Table 116. Avian Influenza Vaccines H9 Strain , by Region USD Million (2025-2030)
  • Table 117. South America Avian Influenza Vaccines, by Country USD Million (2025-2030)
  • Table 118. South America Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 119. South America Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 120. South America Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 121. Brazil Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 122. Brazil Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 123. Brazil Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 124. Argentina Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 125. Argentina Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 126. Argentina Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 127. Rest of South America Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 128. Rest of South America Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 129. Rest of South America Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 130. Asia Pacific Avian Influenza Vaccines, by Country USD Million (2025-2030)
  • Table 131. Asia Pacific Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 132. Asia Pacific Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 133. Asia Pacific Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 134. China Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 135. China Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 136. China Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 137. Japan Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 138. Japan Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 139. Japan Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 140. India Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 141. India Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 142. India Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 143. South Korea Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 144. South Korea Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 145. South Korea Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 146. Taiwan Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 147. Taiwan Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 148. Taiwan Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 149. Australia Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 150. Australia Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 151. Australia Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 152. Rest of Asia-Pacific Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 153. Rest of Asia-Pacific Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 154. Rest of Asia-Pacific Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 155. Europe Avian Influenza Vaccines, by Country USD Million (2025-2030)
  • Table 156. Europe Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 157. Europe Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 158. Europe Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 159. Germany Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 160. Germany Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 161. Germany Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 162. France Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 163. France Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 164. France Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 165. Italy Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 166. Italy Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 167. Italy Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 168. United Kingdom Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 169. United Kingdom Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 170. United Kingdom Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 171. Netherlands Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 172. Netherlands Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 173. Netherlands Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 174. Rest of Europe Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 175. Rest of Europe Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 176. Rest of Europe Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 177. MEA Avian Influenza Vaccines, by Country USD Million (2025-2030)
  • Table 178. MEA Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 179. MEA Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 180. MEA Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 181. Middle East Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 182. Middle East Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 183. Middle East Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 184. Africa Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 185. Africa Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 186. Africa Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 187. North America Avian Influenza Vaccines, by Country USD Million (2025-2030)
  • Table 188. North America Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 189. North America Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 190. North America Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 191. United States Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 192. United States Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 193. United States Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 194. Canada Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 195. Canada Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 196. Canada Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 197. Mexico Avian Influenza Vaccines, by Type USD Million (2025-2030)
  • Table 198. Mexico Avian Influenza Vaccines, by Application USD Million (2025-2030)
  • Table 199. Mexico Avian Influenza Vaccines, by Strain USD Million (2025-2030)
  • Table 200. Avian Influenza Vaccines: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Avian Influenza Vaccines: by Type USD Million (2018-2023)
  • Figure 5. Global Avian Influenza Vaccines: by Application USD Million (2018-2023)
  • Figure 6. Global Avian Influenza Vaccines: by Strain USD Million (2018-2023)
  • Figure 7. South America Avian Influenza Vaccines Share (%), by Country
  • Figure 8. Asia Pacific Avian Influenza Vaccines Share (%), by Country
  • Figure 9. Europe Avian Influenza Vaccines Share (%), by Country
  • Figure 10. MEA Avian Influenza Vaccines Share (%), by Country
  • Figure 11. North America Avian Influenza Vaccines Share (%), by Country
  • Figure 12. Global Avian Influenza Vaccines: by Type USD/Units (2018-2023)
  • Figure 13. Global Avian Influenza Vaccines share by Players 2023 (%)
  • Figure 14. Global Avian Influenza Vaccines share by Players (Top 3) 2023(%)
  • Figure 15. Global Avian Influenza Vaccines share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boehringer Ingelheim Animal Health (France) Revenue, Net Income and Gross profit
  • Figure 18. Boehringer Ingelheim Animal Health (France) Revenue: by Geography 2023
  • Figure 19. QianYuanHao Biological Corporation Limited (China) Revenue, Net Income and Gross profit
  • Figure 20. QianYuanHao Biological Corporation Limited (China) Revenue: by Geography 2023
  • Figure 21. Harbin Veterinary Research Institute (China) Revenue, Net Income and Gross profit
  • Figure 22. Harbin Veterinary Research Institute (China) Revenue: by Geography 2023
  • Figure 23. CEVA (France) Revenue, Net Income and Gross profit
  • Figure 24. CEVA (France) Revenue: by Geography 2023
  • Figure 25. Qingdao Yebio Biological Engineering Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 26. Qingdao Yebio Biological Engineering Co., Ltd (China) Revenue: by Geography 2023
  • Figure 27. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Zoetis Inc. (United States) Revenue: by Geography 2023
  • Figure 29. FATRO S.p.A. (Italy) Revenue, Net Income and Gross profit
  • Figure 30. FATRO S.p.A. (Italy) Revenue: by Geography 2023
  • Figure 31. Merck Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck Animal Health (United States) Revenue: by Geography 2023
  • Figure 33. Global Avian Influenza Vaccines: by Type USD Million (2025-2030)
  • Figure 34. Global Avian Influenza Vaccines: by Application USD Million (2025-2030)
  • Figure 35. Global Avian Influenza Vaccines: by Strain USD Million (2025-2030)
  • Figure 36. South America Avian Influenza Vaccines Share (%), by Country
  • Figure 37. Asia Pacific Avian Influenza Vaccines Share (%), by Country
  • Figure 38. Europe Avian Influenza Vaccines Share (%), by Country
  • Figure 39. MEA Avian Influenza Vaccines Share (%), by Country
  • Figure 40. North America Avian Influenza Vaccines Share (%), by Country
  • Figure 41. Global Avian Influenza Vaccines: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Boehringer Ingelheim Animal Health (France)
  • QianYuanHao Biological Corporation Limited (China)
  • Harbin Veterinary Research Institute (China)
  • CEVA (France)
  • Qingdao Yebio Biological Engineering Co., Ltd (China)
  • Zoetis Inc. (United States)
  • FATRO S.p.A. (Italy)
  • Merck Animal Health (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 213 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Avian Influenza Vaccines research Quantitative research analysis
Global Avian Influenza Vaccines research Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Avian Influenza Vaccines Market are by type [Inactivated Vaccines, Live Recombinant Vaccines and Combination Vaccines], by end use application [Chicken, Duck & Goose and Others].
The Avian Influenza Vaccines Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Awareness About the Avian Influenza Vaccines
  • Growing Demand from Poultry Consumption

Know More About Global Avian Influenza Vaccines research Report?

Have a Query? Click Here

Other Related Reports

N95 Grade Medical Protective Masks Comprehensive Study by Type (Disposable Masks, Reusable Masks), Application (Industrial, Individual, Hospital & Clinic), Distribution Channel (Online, Offline), Ma...
$ 3450
Medicinal Charcoal Tablets Comprehensive Study by Type (Under 0.15 g/piece, 0.15-3 g/piece, Above 0.3 g/piece), Application (Antidiarrheal, Detoxication, Eliminate Swelling), Distribution Channel (Ho...
$ 3450
Healthcare Fabrics Comprehensive Study by Type (Non-Woven Fabrics, Woven Fabrics, Knitted Fabrics), Application (Clothing, Blanket & Bedding, Privacy Curtains, Upholstery, Others), Raw Materials (Pol...
$ 3450
Dental Adhesive Comprehensive Study by Type (Total-Etch, Self-Etch, Selective-Etch), Application (Denture Adhesives, Pit & Fissure Sealants, Restorative Adhesives, Others (orthodontic, dental prosthe...
$ 3750
L-Lysine Comprehensive Study by Type (Type 98, Type 70, Other {Type 65 etc.}), Application (Animal Feed, Food Industry, Healthcare), Sales Channel (Online, Offline) Players and Region - Global Market...
$ 3500
Medical Tapes Comprehensive Study by Application (Fixation, Would Dressing, Others), End-users (Hospitals, Clinics, Others), Distribution Channel (Online Channel, Offline Channel), Material (Paper, P...
$ 3350